TY  - JOUR
T1  - PRevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of us children
AU  - Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS
Y1  - 2007/09/01
N1  - 10.1001/archpedi.161.9.857
JO  - Archives of Pediatrics & Adolescent Medicine
SP  - 857
EP  - 864
VL  - 161
IS  - 9
N2  - Objective 
    To determine the US national prevalence of attention-deficit/hyperactivity disorder (ADHD) and whether prevalence, recognition, and treatment vary by socioeconomic group.Design 
    Cross-sectional survey.Setting 
    Nationally representative sample of the US population from 2001 to 2004.Participants 
    Eight- to 15-year-old children (N = 3082) in the National Health and Nutrition Examination Survey.Main Outcome Measures 
    The Diagnostic Interview Schedule for Children (caregiver module) was used to ascertain the presence of ADHD in the past year based on Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV) criteria. Prior diagnosis of ADHD by a health professional and ADHD medication use were assessed by caregiver report.Results 
    Of the children, 8.7% met DSM-IV criteria for ADHD. The poorest children (lowest quintile) were more likely than the wealthiest (highest quintile) to fulfill criteria for ADHD (adjusted odds ratio [AOR], 2.3; 95% confidence interval [CI], 1.4-3.9). Among children meeting DSM-IV ADHD criteria, 47.9% had a prior diagnosis of ADHD and 32.0% were treated consistently with ADHD medications during the past year. Girls were less likely than boys to have their disorder identified (AOR, 0.3; 95% CI, 0.1-0.8), and the wealthiest children were more likely than the poorest to receive regular medication treatment (AOR, 3.4; 95% CI, 1.3-9.1).Conclusions 
    Of US children aged 8 to 15 years, 8.7%, an estimated 2.4 million, meet DSM-IV criteria for ADHD. Less than half of children meeting DSM-IV criteria report receiving either a diagnosis of ADHD or regular medication treatment. Poor children are most likely to meet criteria for ADHD yet are least likely to receive consistent pharmacotherapy.
SN  - 1072-4710
M3  - doi: 10.1001/archpedi.161.9.857
UR  - http://dx.doi.org/10.1001/archpedi.161.9.857
ER  -